We are live on
!
Find out more
EWM
Essex Woodlands Management Portfolio holdings
AUM
$254M
1-Year Est. Return
4.59%
This Fund
S&P 500
This Quarter
Est. Return
-8.3%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$173M
AUM Growth
-$27.4M
(-14%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-8.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELGX
Endologix Inc
ELGX
|
+$7.72M |
| 2 |
Axogen
AXGN
|
+$6.63M |
| 3 |
ACUR
Acura Pharmaceuticals
ACUR
|
+$352K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.2% |
Similar funds
TSM
LI
LIA
IGM
WWM
MWM
LRIC
CIM
Essex Woodlands Management's Q2 2019 Portfolio in Review
As of Q2 2019, Essex Woodlands Management held 7 positions worth $173M, down 14% from $201M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Essex Woodlands Management withdrew a net $14.7M in Q2 2019, closing 1 position and reducing 2 holdings. Its most notable exit was Acura Pharmaceuticals, an estimated $352K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.
- Essex Woodlands Management's biggest Q2 2019 reduction was Endologix Inc, cutting an estimated $7.72M.
- Essex Woodlands Management fully exited Acura Pharmaceuticals in Q2 2019, selling an estimated $352K.
- Essex Woodlands Management's ten largest holdings make up 100% of its $173M portfolio in Q2 2019.
- Essex Woodlands Management opened 0 new positions and closed 1 in Q2 2019.
- Essex Woodlands Management's portfolio value fell 14% quarter-over-quarter to $173M.
Based on Essex Woodlands Management's 13F filing for Q2 2019, filed 14 Aug 2019.